HCV Ab Test
- UID
- MFG/IVD/2020/000021_bb35c69b8f76fa5749c56131e53bd4f6_136448321c863e937ddd205719ce6afd
- Device class
- Class D
- Brand name
- PathoCatchTM
- License holder
- Mylab Discovery S0lutions Pvt. Ltd
- Approving authority
- Central Drug Standards Control Organization, West Zone
- Product information
- HCV is an in vitro immunochromatographic, rapid assay designed for the qualitative detection of antibodies specific to HCV, in human serum, plasma and capillary blood. HCV Ab test is intended for professional use as the initial test, as an aid to diagnosis. Reactive specimens should be reflexed for additional testing, either by nucleic acid testing (PathoCatchTM) technologies for the detection of HCV RNA or HCV core antigen testing, to identify current HCV infection. This product is intended for use in a population with high HCV prevalence or who have a history of HCV risk exposure/behavior including pregnant women. The performance of the assay has not been established for populations of infants or children
HCV Ab Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000021_bb35c69b8f76fa5749c56131e53bd4f6_136448321c863e937ddd205719ce6afd. This device is marketed under the brand name PathoCatchTM. The license holder is Mylab Discovery S0lutions Pvt. Ltd, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, West Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.